NPI: 1275789588 · CHARLOTTE, NC 28278 · Pediatrics Physician · NPI assigned 08/18/2008
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 08/18/2008 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,945 | $203K |
| 2019 | 5,905 | $226K |
| 2020 | 5,607 | $197K |
| 2021 | 12,380 | $315K |
| 2022 | 24,701 | $387K |
| 2023 | 20,536 | $287K |
| 2024 | 18,464 | $49K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,669 | 7,255 | $554K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5,557 | 4,702 | $257K |
| 99199 | Unlisted special service, procedure or report | 52,770 | 51,839 | $178K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,815 | 1,582 | $174K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,482 | 1,382 | $135K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,326 | 1,120 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 882 | 784 | $85K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5,435 | 4,728 | $53K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,577 | 1,495 | $30K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 793 | 752 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 143 | 135 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 263 | 219 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 391 | 194 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 112 | 89 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 48 | 38 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 179 | 140 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 181 | 173 | $2K |
| 90461 | 2,358 | 1,993 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | 62 | 55 | $2K |
| 92552 | 2,545 | 2,256 | $2K | |
| 90686 | 1,707 | 1,520 | $1K | |
| D1206 | Topical application of fluoride varnish | 62 | 55 | $987.09 |
| 96161 | 115 | 93 | $423.63 | |
| 99177 | 3,287 | 2,918 | $259.98 | |
| 90474 | 12 | 12 | $245.40 | |
| 83655 | 36 | 24 | $179.16 | |
| 96127 | 47 | 40 | $169.68 | |
| 90674 | 423 | 331 | $117.23 | |
| 85018 | 47 | 41 | $21.79 | |
| 36416 | 179 | 136 | $19.32 | |
| 90648 | 121 | 98 | $0.00 | |
| 90670 | 1,039 | 906 | $0.00 | |
| 90633 | 90 | 77 | $0.00 | |
| 90710 | 13 | 13 | $0.00 | |
| 90698 | 306 | 274 | $0.00 | |
| 90680 | 252 | 229 | $0.00 | |
| 90744 | 56 | 51 | $0.00 | |
| 92551 | 88 | 64 | $0.00 | |
| 99174 | 26 | 18 | $0.00 | |
| 90723 | 31 | 27 | $0.00 | |
| 90647 | 13 | 12 | $0.00 |